Podcast: Play in new window | Download
Coagulation Factor Disorders
von Willebrand Disease
- A spectrum of low production to production of poorly functioning von Willebrand’s Factor.
-
von Willebrand’s factor (vWF) has two major functions.
- vWF helps platelets to stick together in the subendothelial collagen
- vWF binds to and maintains Factor VIII in circulation. Factor VIII breaks down very quickly in the bloodstream if not bound to vWF.
- von Willebrand was a pediatrician who first described the disease in 1926
- von Willebrand is the most common inherited clotting disorder
Clinical Presentation
- Easy bruising
- Frequent bloody noses
- Bleeding from gums
- Heavy menstrual periods
Labs and Studies
- Platelets are normal
- PT/INR is normal
- PTT is usually prolonged
- Total plasma von Willebrand factor (VWF) antigen
- VWF function testing
- Plasma factor VIII level
Treatment
- Desmopressin
- Synthetic antidiuretic hormone (vasopressin)
- Stimulates release of vWF
- Factor VIII concentrate
- Platelet concentrates may be given in severe cases
Hemophilia A & B
- Hemophilia A is a deficiency in factor VIII
- Hemophilia B is a deficiency in factor IX
- Hemophilia B is also known as Christmas disease. Stephen Christmas was the first patient diagnosed with the disease in 1953.
- Both are X linked recessive therefore males only need inherit one mutant gene whereas females need to inherit one from each parent
- About 30% of patients have no family history of hemophilia
- Many different mutations cause hemophilia so there is a wide range of severity
Clinical Presentation
- Bleeding
- Prolonged bleeding times from minor injuries
- Muscle and joint pain secondary to hemorrhage
Labs and Studies
- PT/INR are normal
- Platelets are normal
- Bleeding time is normal
- PTT is prolonged
- Low factor VIII
- Low factor IX
Treatment
- In severe cases patients may need factor concentrate. This may be necessary two or three times a week
- Patients may develop an antibody to factor VIII and IX secondary to treatment
- Mild cases may be managed with Desmopressin which will elevate circulating factor VIII
Hemophilia C
- Primarily occurs in Ashkenazi Jews
- There is a deficiency in the coagulation factor XI
- These patients do not have bleeding into the joints
Clinical Presentation
- Symptoms are more mild than other hemophilias and typically do not require treatment
- Prolonged bleeding times
- Frequent nose bleeds
- Heavy menstrual bleeding
Labs, Studies and Physical Exam Findings
- No blood bleeding test will isolate a factor XI deficiency
Treatment
- Treatment is usually unnecessary unless there is severe trauma or surgery
- Fresh frozen plasma
- Platelets
- Desmopressin
Platelet dysfunction
- Normal platelet count is between 150,000 and 450,000
- Thrombocytopenia is defined as a platelet count below 50,000
-
Petechiae
- Red or purple discoloration of the skin that do not blanch
- They are 1-3mm in size
-
Purpura
- Red or purple discoloration on the skin that do not blanch.
- These are 3mm – 10mm in size
- This can be poor production, increased destruction or use of platelets, splenic sequestration or dilution.
-
Megathrombocytes
- Immature platelets recently released from the bone marrow.
Idiopathic Thrombocytopenic Purpura (ITP)
- Autoimmune disease with anti-platelet antibodies
- The acute form of this disease happens in children typically following an upper respiratory infection
- The chronic form of this disease occurs in adults
- A majority of patients have platelet antibodies
Clinical Presentation
- Sudden onset of petechiae and purpura found on mucous membranes and on the skin
- Severe nosebleed
- Excessive menstrual bleeding
- Noticeably long bleeding times
Labs, Studies and Physical Exam Findings
- Petechiae and purpura are found on the skin and mucous membranes
- Low platelet with no apparent reason
- Peripheral blood smear may show megathrombocytes
- This is a diagnosis of exclusion so a complete hematologic workup may be necessary
- Peripheral blood smear may show megalothrombosites
- Anti- platelet antibodies may be detectable
Treatment
- Avoid aspirin and NSAIDS
- Typically no treatment is necessary for either acute or chronic disease
- Steroids
- Splenectomy – reduces platelet destruction but the surgery has obvious risk
- Platelet transfusion in cases of severe trauma